Setting 
My Cart

Ordered before 17:30, shipped today - Support: (012) 800 456 789

Track Your Order

Toggle Nav
mobile icon
Close
  • Menu
  • Setting
  • Home
  • Search results for: 'research area jak stat signaling egfr'

Search results for: 'research area jak stat signaling egfr'

Items 1-10 of 103

Page
per page
  1. Cucurbitacin I
    A4512 Cucurbitacin I
    Target: STAT|JAK
    Summary: STAT3/JAK2 signaling inhibitor
      ≥22.45 mg/mL
  2. Stattic
    A2224 Stattic
     5 Citation
    Target: STAT
    Summary: STAT3 inhibitor,small-molecule and potent
      insoluble in H2O; insoluble in EtOH; ≥10.56 mg/mL
  3. NSC 74859
    A8338 NSC 74859
     5 Citation
    Target: STAT
    Summary: Stat3 inhibitor
      insoluble in H2O; ≥18.25 mg/mL
  4. Fludarabine
    A5424 Fludarabine
    Summary: DNA synthsis inhibitor
      insoluble in H2O; insoluble in EtOH; ≥9.25 mg/mL
  5. Afatinib (BIBW2992)
    A8247 Afatinib (BIBW2992)
     1 Citation
    Target: EGFR
    Summary: Irreversible EGFR/HER2 inhibitor
      ≥24.3 mg/mL
  6. AG-490
    A4139 AG-490
     3 Citation
    Target: EGFR|JAK
    Summary: JAK2/EGFR inhibitor
      insoluble in H2O; ≥14.7 mg/mL
  7. Gefitinib (ZD1839)
    A8219 Gefitinib (ZD1839)
     3 Citation
    Target: EGFR
    Summary: Selective EGFR inhibitor
      ≥22.34 mg/mL
  8. Lapatinib
    A8218 Lapatinib
     2 Citation
    Target: ErbB
    Summary: EGFR/HER2 inhibitor,potent,selective and reversible
      ≥29.05 mg/mL
  9. Tofacitinib (CP-690550) Citrate
    A4135 Tofacitinib (CP-690550) Citrate
     2 Citation
    Target: JAK
    Summary: Potent JAK inhibitor
      ≥25.22 mg/mL
  10. CP-724714
    A2412 CP-724714
    Target: VEGFR|PDGFR|Bcr-Abl|Src|EGFR|c-MET|Insulin Receptors|IRG-1R
    Summary: HER2 inhibitor,potent and selective
      ≥23.5 mg/mL

Items 1-10 of 103

Page
per page
Shop By
Now Shopping by
  1. Specificity Selective Remove This Item
  2. Reported Experiments Animal Experiments Remove This Item
Clear All
Shopping Options
Category
  1. Signaling Pathways 102item
Reversibility
  1. Reversible 6item
  2. Irreversible 3item
Target
  1. Akt 4item
  2. PI3K 10item
  3. Raf 6item
  4. mTOR 6item
  5. Androgen Receptors 1 item
  6. FLT3 1 item
  7. GSK-3 5item
  8. P-glycoprotein (P-gp) 1 item
  9. VEGFR 6item
  10. PDGFR 3item
  11. Phosphodiesterases (PDEs) 1 item
  12. p38 4item
  13. PKB 1 item
  14. JNK 2item
  15. Bcr-Abl 1 item
  16. MEK 4item
  17. PORCN 1 item
  18. FGFR 3item
  19. Nrf2 1 item
  20. GABAB Receptors 1 item
  21. Smoothened 1 item
  22. MET 1 item
  23. Src 2item
  24. STAT 5item
  25. EGFR 13item
  26. Hedgehog 1 item
  27. BMP and Other Activin Receptors 2item
  28. JAK 10item
  29. Syk 2item
  30. HSP90 1 item
  31. TNKS 1 item
  32. ErbB 2item
  33. Toll-like receptors (TLRs) 1 item
  34. ERK 1 item
  35. c-MET 1 item
  36. PKC 3item
  37. HER2 2item
  38. Melanocortin (MC) Receptors 1 item
  39. Fatty-acid-binding proteins (FABPs) 1 item
  40. NO Donors / Precursors 1 item
  41. IL Receptors 1 item
  42. Insulin Receptors 1 item
  43. IRG-1R 1 item
  44. c-RET 1 item
  45. TYK2 1 item
Related Disease
  1. Acute Myelogenous Leukemia 1 item
  2. Acute Myeloid Leukemia 3item
  3. Bladder Cancer 2item
  4. Breast Cancer 25item
  5. Cancer 75item
  6. Cervical Cancer 2item
  7. Colon Cancer 9item
  8. Colon Carcinoma 1 item
  9. Colorectal Cancer 11item
  10. Glioblastoma 11item
  11. Glioma 3item
  12. Hepatocellular Carcinoma 1 item
  13. HIV Infections 1 item
  14. Immunological Diseases 1 item
  15. Inflammatory Bowel Disease 1 item
  16. Leukemia 8item
  17. Liver Cancer 2item
  18. Lung Cancer 8item
  19. Lymphoma 3item
  20. Melanoma 5item
  21. Multiple Myeloma 2item
  22. Myelofibrosis 1 item
  23. Myeloma 1 item
  24. Neuroblastoma 2item
  25. Non-small Cell Lung Cancer 6item
  26. Ovarian Cancer 7item
  27. Pancreatic Cancer 11item
  28. Pancreatic Carcinoma 2item
  29. Prostate Cancer 14item
  30. Psoriasis 1 item
  31. Pulmonary Arterial Hypertension 1 item
  32. Pulmonary Fibrosis 1 item
  33. Renal Cancer 1 item
  34. Renal Cell Carcinoma 1 item
  35. Rheumatoid Arthritis 4item
  36. Thyroid Cancer 2item
  37. Type 2 Diabetes 2item